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Principles: Respiratory care is universally
recognised as useful, but its indications and prac-
tice vary markedly. In order to improve the ap-
propriateness of respiratory care in our hospital,
we developed evidence-based local guidelines in a
collaborative effort involving physiotherapists,
physicians and health service researchers.
Methods: Recommendations were developed
using the standardised RAND appropriateness
method. A literature search was conducted based
on terms associated with guidelines and with res-
piratory care. A working group prepared propos-
als for recommendations which were then inde-
pendently rated by a multidisciplinary expert
panel. All recommendations were then discussed
in common and indications for procedures were
rated confidentially a second time by the experts.
The recommendations were then formulated on
the basis of the level of evidence in the literature
and on the consensus among these experts.
Results: Recommendations were formulated
for the following procedures: non-invasive venti-
lation, continuous positive airway pressure, inter-
mittent positive pressure breathing, intrapul-
monary percussive ventilation, mechanical insuf-
flation-exsufflation, incentive spirometry, positive
expiratory pressure, nasotracheal suctioning and
non-instrumental airway clearance techniques.
Each recommendation referred to a particular
medical condition and was assigned to a hier-
archical category based on the quality of the
evidence from the literature supporting the rec-
ommendation and on the consensus among the
experts.
Conclusion: Despite a marked heterogeneity of
scientific evidence, the method used allowed us to
develop commonly agreed local guidelines for
respiratory care. In addition, this work fostered a
closer relationship between physiotherapists and
physicians in our institution.
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Summary
The usefulness of respiratory care in the
acute care hospital is widely recognised. However,
in spite of its generally undisputed value, the indi-
cations for and practice of respiratory care vary
markedly among different hospitals, and even
within the same institution [1–3]. Respiratory
care is labour-intensive and its development is in-
evitably limited by institutional budget con-
straints. Hence the appropriateness of care deliv-
ered is important, since unnecessary care wastes
resources and undelivered indicated care may ad-
versely affect patient outcome. A recent study
conducted in an acute care hospital found that
this was not always the case: 25% of respiratory
care procedures delivered were not indicated,
whereas 12% of patients were not receiving respi-
ratory care that was indicated [4].
In view of an increasing number of demands
for respiratory care and the variety of habits and
practices in our institution, the Department of
Physiotherapy decided to establish scientifically
sound local guidelines for respiratory care. The
field was limited to respiratory care procedures in
the adult patient, excluding invasive ventilation. In
addition to classic chest physiotherapy, the project
included non-invasive ventilatory support since the
latter procedures represent an increasing part of the
chest physiotherapists’ work in our hospital.
Introduction
No conflict
of interest.
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Material and methods
Setting
This study was conducted at Lausanne University
Hospital, a 900-bed acute care teaching hospital. The
project was initiated in collaboration with the Institute of
Social and Preventive Medicine, the Department of Res-
piratory Medicine, and the Department of Adult Inten-
sive Care Medicine in our hospital.The institutional Eth-
ical Committee does not require approval for studies that
do not directly involve patients.
Composition of working group and of expert panel
A working group piloting the project was composed
of five physiotherapists and four physicians. A multidisci-
plinary expert panel of 13 members was consulted (11
members from Lausanne University Hospital, and two
from Geneva University Hospital). The panel was com-
posed of three specialists in respiratory medicine, two
physiotherapists, two specialists in intensive care medi-
cine, two specialists in internal medicine, one thoracic
surgeon, one cardiovascular surgeon, one abdominal sur-
geon, and one specialist in otorhinolaryngology.
Respiratory care procedures
– Non-invasive ventilation (NIV): in this document, NIV
refers to positive pressure ventilation applied through
a facial or a nasal mask.
– Continuous positive airway pressure (CPAP): breathing
mode by which the patient spontaneously breathes
through a pressurised circuit that maintains a preset
positive airway pressure during both inspiration and
expiration.
– Intermittent positive pressure breathing (IPPB): short-
term ventilation technique involving patient-triggered
delivery of positive airway pressure during inspiration.
– Intrapulmonary percussive ventilation (IPV): airway
mucus clearance technique involving internal thoracic
percussion through the delivery of pulsatile air flow
during inspiration.
– Mechanical insufflation-exsufflation (MIE) (Cough As-
sist

): technique of mechanical cough assistance in-
volving a positive pressure insufflation followed by a
rapid negative pressure exsufflation.
– Incentive spirometry (IS): technique encouraging the
patient to perform sustained maximal inspirations by
providing a feedback according to a predetermined
flow or volume.
– Positive expiratory pressure (PEP): the PEP-mask is an
airway mucus clearance technique involving a face
mask or a mouthpiece and a one-way valve to which an
expiratory resistance is attached. The blow bottle cre-
ates a PEP when the patient exhales through an under-
water tube. The Flutter VRP1

is a technique of airway
mucus clearance involving a pipe-shaped device con-
taining a steel ball. During expiration through the de-
vice, the rise and fall of the steel ball creates an oscilla-
tory positive pressure and vibration of the airways.
– Nasotracheal suctioning: airway mucus clearance tech-
nique involving the insertion of a suction catheter
through the nose into the trachea without a tracheal
tube.
– Non-instrumental airway clearance techniques: Autogenic
drainage consists of breathing at different lung vol-
umes and maximising expiratory flow to clear airway
secretions. Initially the patient breathes for a few min-
utes below functional residual capacity and then pro-
gressively breathes at higher lung volumes. Active cycle
of breathing techniques (ACBT) combines diaphragmatic
breathing, deep breathing and forced expiration.Man-
ual chest percussion consists of rapid hand clapping onto
the chest.
Literature search
A literature search was performed for the period be-
tween January 1995 andMarch 2009 based on terms associ-
ated with guidelines and with respiratory care. The follow-
ing databases were used: Medline, Biosis, Cinhal, Embase,
Web of sciences, Pubmed, Cochrane Library, National
Guideline Clearinghouse, links to Evidence Based
Medicine websites (www.guideline.gov; www.ahrq.gov;
www.anaes.fr ), Altavista, Google, textbooks and consen-
sus conferences in chest physiotherapy, references quoted
by existing guidelines, by systematic reviews and by origi-
nal studies.
Quality of evidence
The Oxford quality of evidence classification was
used (www.cebm.net/levels_of_evidence.asp). This classi-
fication consists of five levels of evidence which are pre-
sented in table 1. For each respiratory care procedure the
best evidence was sought, considering literature in the
following order: 1) evidence mentioned in high quality
guidelines using the AGREE framework (5); 2) evidence
mentioned in high quality systematic reviews; 3) evidence
found in studies of various types.
Evidence level I:
– Randomised controlled trials
– Systematic reviews of randomised controlled trials (homogeneous)
– Systematic reviews
Evidence level II: Non-randomised controlled trials
Evidence level III: Prospective cohort studies
Evidence level IV: Retrospective cohort studies, case-control studies
Evidence level V: Case studies, published expert opinions
Table 1
Levels of evidence
of publications.
A: Strong evidence supporting recommendation or acceptable evidence with strong consensus among experts
Evidence level I (randomised controlled trials, systematic reviews of randomised controlled trials or systematic reviews) or
Evidence level II (non-randomised controlled trials) or III (prospective cohort studies) with strong consensus among experts
B: Acceptable evidence supporting recommendation or sufficient evidence with strong consensus among experts
Evidence level II (non-randomised controlled trials) or III (prospective cohort studies) or
Evidence level IV (retrospective cohort studies, case-control studies) or V (case studies, published opinions of experts) with strong
consensus among experts
C: Sufficient evidence supporting recommendation
Evidence level IV (retrospective cohort studies, case-control studies) or V (case studies, published opinions of experts)
and Consensus within the expert group to formulate recommendations
I: Insufficient evidence supporting recommendation or evidence considered globally uncertain by the expert group
When there is insufficient evidence, for instance in the case of conflicting studies or divergent expert opinions, no recommendation is
formulated and the decision has to be made in the light of specific circumstances, essentially according to the clinician’s judgement
Table 2
Categories of
recommendations.
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Strength of recommendations
In this study the strength of recommendations was
based both on the quality of evidence extracted from the
literature and on the expert consensus, as detailed further
on. The categories of recommendations used are pre-
sented in table 2.
Development of recommendations
Recommendations were developed using the stan-
dardised procedures of the RAND appropriateness
method [6, 7]. A synthesis of the literature on the appro-
priateness of each respiratory care procedure in various
medical conditions was drawn up, and on its basis the
working group established proposals for recommenda-
tions. These proposals and the relevant literature were
mailed to the members of the expert panel. Each proce-
dure for respiratory care was rated separately for several
conditions on a 9-point scale (1 = extremely inappropri-
ate, 5 = uncertain, 9 = extremely appropriate) by the 13
experts.
After this the experts met with the working group
and were provided with reports showing their initial rat-
ings and the anonymous distribution of other experts’
ratings. All recommendations were discussed and the ex-
perts rated indications for procedures confidentially a
second time. Following the procedure for the RAND ap-
propriateness method, each indication was classified as
appropriate, uncertain, or inappropriate, on the basis of
the panel median rating (1–3 = inappropriate; 4–6 = un-
certain; 7–9 = appropriate) and the degree of intra-panel
agreement. All indications for which there was disagree-
ment were classified as uncertain, irrespective of the
panel’s median score.
The recommendations were then formulated on the
basis of the level of evidence in the literature and on the
consensus of experts, as per table 2.
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Condition Technique Recommendation Comments References
COPD
Hypercapnic respiratory failure NIV Recommended (A) Indication: pH 7.25–7.35 [9–15]
and PaCO
2
≥50 mm Hg
Secretion retention Non-instrumental Recommended (A) [2, 16–22]
airway clearance
Nasotracheal suctioning Recommended (B) If other techniques fail [2, 23–25]
PEP Uncertain (I) [19, 21, 26]
IPV Uncertain (I) [27]
IPPB Not recommended (C) [28]
MIE Not recommended (C) [29]
Asthma NIV Not recommended (A) [10, 11, 13]
IPPB Not recommended (C) [28, 30]
Cystic fibrosis
Hypercapnic respiratory failure NIV Recommended (C) [10, 13, 14, 31, 32]
Secretion retention Non-instrumental Recommended (A) |2, 16–22]
airway clearance
PEP-mask Recommended (A) [18, 19, 22]
Flutter VRP1 Recommended (C) [19, 21, 26, 33]
Nasotracheal suctioning Recommended (C) If other techniques fail [2, 23–25]
IPV Uncertain (I) If other techniques fail [18, 19, 21, 22, 26, 33]
IPPB Not recommended (C) [21, 30]
MIE Not recommended (C) [29]
Upper airway obstruction NIV Recommended (C) Indication: glottal oedema [13]
following extubation
Aerosol delivery IPPB Not recommended (C) [30]
COPD: chronic obstructive pulmonary disease; IPPB: intermittent positive pressure breathing; IPV: intrapulmonary percussive
ventilation; MIE: mechanical insufflation-exsufflation; NIV: non-invasive ventilation; PEP: positive expiratory pressure
Table 3
Recommendations
for obstructive
disorders.
Condition Technique Recommendation Comments References
Obesity hypoventilation syndrome NIV Recommended (C) [9, 10, 13, 14]
Central hypoventilation NIV Recommended (C) [9, 10, 13, 14]
Chest wall deformity with hypercapnic respiratory failure NIV Recommended (C) [9, 10, 13, 14]
Neuromuscular disease
Hypercapnic respiratory failure NIV Recommended (C) [9, 10, 13, 14]
Impaired cough MIE Recommended (C) [2, 19, 34, 35]
Spinal cord injury IPPB Not recommended (A) For C5 – T6 lesions [36]
IPPB: intermittent positive pressure breathing; MIE: mechanical insufflation-exsufflation; NIV: non-invasive ventilation
Table 4
Recommendations
for restrictive
disorders.
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Condition Technique Recommendation Comments References
Cardiogenic pulmonary CPAP Recommended (A) As adjunct to drug therapy [9, 10, 14, 28, 37–41]
oedema
NIV Recommended (A) If CPAP fails. Indication: PaO
2
/FiO
2
≤200 mm Hg [9, 10, 13, 14, 41]
and RR ≥35/min Employed in ICU
ARDS NIV Uncertain (I) Employed in ICU [42–44]
Pneumonia
Hypoxaemic respiratory CPAP Recommended (A) [10, 45]
failure
NIV Recommended (A) Indication: PaO
2
/FiO
2
≤200 mm Hg and RR ≥35/min [9, 10, 12–14]
Employed in ICU
Hypercapnic respiratory NIV Recommended (A) Employed in ICU [10, 46]
failure
Secretion retention Non-instrumental Recommended (A) [16–18, 20–23, 25, 47]
airway clearance
No secretion retention Chest physiotherapy Not recommended (A) [48, 49]
ARDS: acute respiratory distress syndrome; CPAP: continuous positive airway pressure; ICU: intensive care unit;
NIV: non-invasive ventilation; RR: respiratory rate
Table 5
Recommendations
for pulmonary
oedema and
pneumonia.
Condition Technique Recommendation Comments References
Pulmonary atelectasis CPAP Recommended (A) [10, 28, 47, 50–52]
NIV Not recommended (A) Not superior to CPAP [53]
IS Recommended (B) As adjunct to CPAP [54]
PEP Uncertain (I) [22]
Chest trauma with hypoxaemia CPAP Recommended (A) [10, 13]
NIV Recommended (C) Applied in ICU [13]
Postoperative hypoxaemia CPAP Recommended (A) [52]
NIV Recommended (A) Post lung resection or solid organ transplantation [10, 13, 55, 56]
Applied in ICU
Bronchoscopy in cases of hypoxaemia CPAP Recommended (A) Indication:PaO
2
/FiO
2
≤200 mm Hg [57]
NIV Recommended (A) Indication:PaO
2
/FiO
2
≤200 mm Hg [58]
Postoperative prophylactic PEP Uncertain (I) [59, 60]
physiotherapy
IS Uncertain (I) [59, 61–63]
CPAP Uncertain (I) [59]
NIV Uncertain (I) [64, 65]
Terminal disease with severe dyspnoea NIV Recommended (C) As part of an integrated palliative care project [66]
To be discontinued in the absence of subjective benefit
CPAP: continuous positive airway pressure; IS: incentive spirometry; NIV: non-invasive ventilation; PEP: positive expiratory pressure
Table 6
Recommendations for atelectasis, hypoxaemia and severe dyspnoea.
Results
Recommendations were established for each
respiratory care procedure, as validated in differ-
ent medical conditions. To facilitate the use of
recommendations by physicians prescribing respi-
ratory care, they are presented here using the
medical condition as entry. Each recommendation
is associated with its degree of strength (A, B, C,
or I), with references, and in some cases with addi-
tional comments pertaining either to the evidence
in the literature or to local implementation of rec-
ommendations in our hospital. The recommenda-
tions are presented in tables 3–6.
Discussion
The decision to implement guidelines for
respiratory care in our hospital arose from the ob-
servation of increasing demand and from the per-
ception that some procedures were not always
prescribed on rigorous grounds. While scientifi-
cally based guidelines exist for certain respiratory
care procedures, we felt that for several reasons
developing local guidelines would be more benefi-
cial than importing existing ones. Firstly, the
expertise and role of various professionals – physi-
cians, physiotherapists and nurses – differs be-
tween hospitals for historical reasons. Secondly,
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the structure and tasks of different care units, such
as the intensive care unit (ICU), intermediate care
units and general ward, also vary from institution
to institution [3]. Finally, because the prescription
and delivery of respiratory care is often influenced
by local habits, we anticipated that changes would
be facilitated by a sense of identification with
homegrown guidelines [8]. With this aim, the
expert panel was composed of 13 members origi-
nating from eight different specialities and was
intended to represent the variety of physicians
prescribing respiratory care procedures. The ma-
jority of experts originated from our institution,
but two were invited from another similar univer-
sity hospital to have the benefit of an outside view.
The scientific evidence supporting the differ-
ent respiratory care procedures was found to be
very heterogeneous. The usefulness of and indica-
tions for recent techniques such as non-invasive
ventilation were found to rest on a wealth of ran-
domised controlled trials, systematic reviews and
meta-analyses. In contrast, the usefulness of more
longstanding procedures, such as airway clearance
techniques, was affected by a lack of scientific sup-
port. This is in part explained by the methodolog-
ical problems of studying chest physiotherapy
techniques, such as the absence of appropriate
sham procedures and the difficulty of blinding
participants to physiotherapy interventions. Use
of the RAND appropriateness method was partic-
ularly effective in enabling us to reach a consensus
and formulate recommendations in the face of
scant scientific evidence. This procedure was easy
to follow for professionals of various backgrounds
who were experiencing it for the first time.
The development of guidelines for respira-
tory care inevitably raised the question of their
relevance and implementation in our hospital. For
instance, non-invasive ventilation is now a well es-
tablished technique which is employed in differ-
ent settings: in the emergency room, in the ICU,
in intermediate care units, and even in the general
ward for patients preparing for home mechanical
ventilation. For each medical condition, the ap-
propriate clinical setting for this therapy has to be
decided in the light of local facilities and infra-
structure, and personnel expertise [3]. Thus, for
some indications the expert panel recommended
that the use of non-invasive ventilation must be
restricted to the ICU or must be discussed with
the ICU’s physician if it was intended to employ it
outside the ICU. Although not valid beyond our
institution, these comments illustrate a case of
local implementation. Beyond the initial goal of
publishing recommendations for respiratory care
procedures, the joint development of guidelines
had the valued advantage of building a common
culture and a closer relationship between physio-
therapists and physicians.
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